5.jpeg)
Johnson & Johnson has applied for the Emergency Use Authorisation (EUA) of its single-dose Covid-19 vaccine, said an official statement issued by the US-based pharmaceutical company on Friday.
"On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for Emergency Use Authorisation (EUA) of its single-dose covid-19 vaccine to the Government of India," read the statement.
Johnson & Johnson claimed that its single-shot vaccine, in clinical trials, proved to be 85 per cent effective in preventing severe disease. The vaccine also showed protection against Covid-19 related hospitalisation and death, it said.
Johnson & Johnson has applied for the Emergency Use Authorisation (EUA) of its single-dose Covid-19 vaccine, said an official statement issued by the US-based pharmaceutical company on Friday.
"On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for Emergency Use Authorisation (EUA) of its single-dose covid-19 vaccine to the Government of India," read the statement.
Johnson & Johnson claimed that its single-shot vaccine, in clinical trials, proved to be 85 per cent effective in preventing severe disease. The vaccine also showed protection against Covid-19 related hospitalisation and death, it said.
139.jpeg)
260.jpeg)
259.jpeg)
258.jpeg)
